Longevity Services & Practice Library
Every article, presentation, spotlight, and news item we've tagged to Longevity Services & Practice.
Showing 169–192 of 245
#382 ‒ AMA #80: Longevity optimization through strength benchmarks, VO₂ max targets, nutrition principles, brain health, supplements, GLP-1 RAs, wearables, and more
Exercise emerges as the most protective intervention for brain health across the lifespan, with specific performance benchmarks in strength and aerobic capacity serving as measurable proxies for cognitive preservation and longevity. This positions physical capacity as a foundational biomarker that integrates multiple physiological systems rather than a secondary health outcome.
Antiaging shifts upstream as cell wellness gains traction
The personal care and longevity industry is shifting from treating visible signs of aging to supporting cellular health upstream, positioning products as maintenance tools for biological function rather than cosmetic fixes. This repositioning extends the customer lifecycle while aligning consumer expectations with the biological mechanisms of aging.
Rejuvenation Roundup March 2026
This roundup summarizes March 2026 longevity research across multiple domains: mechanisms linking energy production to neurodegeneration, exercise's effect on brain aging, immunosenescence factors, organ-level aging processes, and the interconnection between microbiome composition, psychological state, and systemic aging. The findings collectively advance understanding of how interventions—from resistance training to nutritional composition to social environment—modulate the rate of age-related decline.
Longevity Research July 2026: Mechanisms Advance, Clinical Translation Lags
July 2026 research advances span intermittent fasting, calcium homeostasis, thymic regeneration, and senolytic therapies in animal models, alongside policy discussions on physical activity guidelines and cautionary evidence from a fatal NAD⁺ infusion. The month illustrates both the promise and peril of experimental longevity interventions—mechanistic progress tempered by real-world safety failures and the gap between animal findings and clinical application.
Senescent cell clearance and stem cell therapy extend lifespan 70%
A dual-therapy approach combining senescent cell clearance with mesenchymal stem cell restoration produced a 70% lifespan extension in mice, accompanied by sustained improvements in physiological function. This preclinical result demonstrates that coordinated interventions targeting cellular aging and tissue regeneration can produce measurable longevity gains.
#385 – AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more
This AMA addresses practical applications of longevity science across disease prevention, body composition assessment, nutritional strategy, movement quality, and habit implementation. The focus is on translating evidence-based tools into sustained clinical and personal practice for extending both lifespan and healthspan.
Aging Science Stalled: Why Policy Reform Precedes Patient Access
Longevity research has advanced substantially in laboratories, but regulatory and policy frameworks have not kept pace, creating a critical bottleneck between scientific discovery and patient access. The Alliance for Longevity Initiatives is working to integrate aging science into mainstream health policy, treating healthy longevity as a national priority rather than a niche scientific interest.
Capriroso launches platform for athlete longevity
Capriroso's platform interprets biometric data across weeks and months rather than daily snapshots, helping endurance athletes recognize long-term physiological patterns and make training decisions based on cumulative stress and recovery trends. This approach addresses a gap where abundant data has not improved understanding, potentially extending athletic lifespan through sustainable training practices.
Your immune system now has a digital twin for longevity
A digital twin technology modeling immune system dynamics in real time enables predictive health outcomes rather than reactive assessment. This shift from static testing to continuous simulation represents a substantive advance in personalized longevity medicine.
Aging research priorities reshape translational longevity science
The GIMM Festival convened international researchers, clinicians, and stakeholders to identify priority research questions that should guide the aging and longevity field forward. The consensus-driven approach produced a shared roadmap addressing scientific gaps, clinical translation, and societal implications of aging research.
Healthspan Replaces Lifespan in Insurance Risk Models
Insurance industry faces structural pressure to shift from mortality-focused actuarial models toward healthspan optimization as prevention, morbidity reduction, and health data reshape risk assessment. Insurers capable of actively shaping healthy aging outcomes—rather than passively financing disease burden—will gain competitive advantage in an aging demographic landscape.
Insilico forms longevity board to oversee AI aging research
Insilico Medicine established an oversight board combining pharmaceutical expertise with longevity science to accelerate AI-driven drug discovery targeting aging hallmarks. The initiative aims to translate experimental compounds into validated therapeutics across fibrosis, oncology, immunology, and metabolic disease.
Allosteric Bioscience targets longevity research using AI and quantum computing
Allosteric Bioscience is using AI and quantum computing to model molecular mechanisms of aging, targeting pathways including Lamin A, tryptophan metabolism, DNA repair, and mitochondrial function. The approach aims to identify modulators that could reduce age-related disease and extend lifespan.
Insilico forms industry’s first AI Longevity Board
Insilico Medicine has established an industry-focused Longevity Board to guide AI-driven drug development targeting aging itself rather than individual diseases. The board represents a shift from academic longevity research toward pharmaceutical scalability, with leadership from both the biotech sector and major pharmaceutical companies.
Abu Dhabi’s “Future Health” initiative targets longevity, predictive care
Abu Dhabi is establishing a large-scale health infrastructure combining genomic, phenotypic, and wearable data with AI to enable predictive care and accelerate drug discovery. This represents a shift toward population-level early detection and prevention rather than reactive treatment models.
AI app puts longevity data in your pocket
Human Longevity has launched a mobile application that consolidates clinical data, biomarkers, genetic information, and imaging results into a continuous health record accessible to users. The platform uses AI to identify patterns across longitudinal data, shifting preventive health assessment from episodic annual checkups to real-time risk monitoring and interpretation.
Function acquires Getlabs to scale at-home testing
Function's acquisition of Getlabs removes logistical friction from routine health testing by bringing blood draws directly to patients' homes and offices. This operational change addresses a fundamental barrier to consistent health monitoring—the primary prerequisite for sustained, data-driven health optimization.
Executive Health program condenses three months of testing into six hours
Biograph's Executive Physical consolidates comprehensive cardiovascular, metabolic, cancer, and neurological screening into a single six-hour appointment using whole-body MRI, advanced CT, and biomarker analysis. This integrated approach identifies significant health findings in approximately 17 percent of participants and demonstrates measurable metabolic improvements in follow-up assessments.
Klotho Therapy Gains Direct Researcher-Patient Dialogue Model
GARM Clinic convened three leading Klotho researchers with 22 participants receiving a Klotho-based intervention, creating direct dialogue between scientists and patients—a rare model in longevity medicine that reflects shifting expectations for transparency and engagement in therapeutic development.
Global rallies call for aging to be treated
Coordinated global demonstrations are pressuring governments to fund geroscience research and establish regulatory pathways that recognize aging as a treatable medical condition. The rallies highlight a critical gap between accelerating scientific advances in longevity research and stalled policy frameworks that remain anchored to disease-specific treatment models.
Ageist Language Reduces Health Compliance and Longevity
Research over the past decade reveals ageism embedded in language patterns across healthcare, media, and social contexts—a finding that directly shapes how patients interpret health messaging and comply with medical guidance. The way aging is linguistically framed influences both psychological resilience and health behavior, making communication precision a measurable longevity factor.
L-Nutra named Innovator Partner for the Longevity Show 2026
L-Nutra's fasting-mimicking technology platform, validated across 47 clinical trials and 18 university research centers, repositions precision nutrition as essential healthcare infrastructure rather than lifestyle optimization. The company's approach uses targeted nutrient formulations to trigger cellular repair mechanisms—autophagy and metabolic signaling—without the physiological stress of extended fasting, addressing metabolic dysfunction and age-related chronic disease at a systems level.
Aging Biomarkers Emerge as Geroscience's Real Bottleneck
The 6th TimePie Longevity Forum in Shanghai brought together approximately 2,500 participants from 16 countries across aging biology, biomarker development and clinical geroscience. Discussion centered on building biomarker frameworks robust enough to guide the testing of interventions in humans, rather than on mechanistic discovery alone. The translational bottleneck in geroscience remains measurement: without validated indicators of biological aging, intervention trials lack meaningful endpoints.
Body Composition Tracking Outperforms Weight in Longevity Assessment
Restore Hyper Wellness is offering free InBody body composition scans and wellness consultations through August as part of a National Wellness Month campaign. The company references a six-month peer-reviewed study showing that weight changes in participants derived primarily from fat loss while preserving lean muscle mass, underscoring the clinical value of tracking composition rather than scale weight alone.